STMicroelectronics announced Wednesday that the federal district court in New York confirmed the arbitration in his favor in February 2009 against Credit Suisse for more than 431 million dollars (322 million) including interest.
The maker of semiconductors said this new court decision confirmed "the validity of an arbitration decision made unanimously in his favor by the FINRA (Financial Industry Regulatory Authority) in February 2009.
"The decision of the federal district court in New York rejected the motion of Credit Suisse to set aside the arbitration award, announced the Franco-Italian in a statement.
The U.S. court has "also given the right to request STMicroelectronics to obtain confirmation of the arbitration decision and order Credit Suisse to pay the company the balance of the amount due," says he.
Based on this decision, STMicro will receive about $ 354 million, which includes about 23 million dollars in interest to date, in addition to nearly 75 million received last December from the sale of a part of the obligations ARS (Auction Rate Securities).
Around 1135, under the STM, which was briefly stimulated by this information came around previous levels (2.09% to 7.05 euro).
STMicroelectronics has launched action against Credit Suisse for the reimbursement of the amount he deemed "unduly invested" in bonds risky ARS, contrary to his instructions.
The Franco-Italian chip, headquartered in Geneva, had given more than 450 million dollars to the Swiss institution with a mandate to invest the money in safe securities.
In February 2009, Credit Suisse had been sentenced by a New York court over $ 406 million dollars of electronic components for fraud.
According to the ruling last month, the money had been invested in the market for "subprime" and then lost.
This decision was highly anticipated because it could encourage other groups suffering from mismanagement to imitate STMicroelectronics.
Roche has also filed a complaint for the same reasons last October against Credit Suisse before a New York court.
The Swiss bank had invested 545 million dollars in securities to financial risk on behalf of pharmaceutical, despite her having asked to make investments safe.